Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- EQL.ST
- Price
- 59.10
- Stock movement up
- +1.60 (2.71%)
- Company name
- EQL Pharma AB
- Exchange
- (ST ,
- Currency
- SEK )
- Market cap
- -
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- 4.75%
- Div growth
- 8.43%
- Growth years
- 1
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-10-31
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 2.88 |
| Dividend yield | 4.75% |
| Payout frequency | Quarterly |
| Maximum yield | 5.03% |
| Average yield | 4.53% |
| Minimum yield | - |
| Discount to avg yield | 4.68% |
| Upside potential | 4.91% |
| Yield as % of max yield | 94.40% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 4.75% |
| Current yield distribution | 53.57% |
| Yield at 100% (Min) | - |
| Yield at 90% | 4.30% |
| Yield at 80% | 4.38% |
| Yield at 50% (Median) | 4.76% |
| Yield at 20% | 4.88% |
| Yield at 10% | 4.92% |
| Yield at 0% (Max) | 5.03% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | 1 years |
| CCC status | - |
| Dividend per share | 2.88 |
| Payout frequency | Quarterly |
| Ex-div date | 22 Dec 2022 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| EQL.ST | S&P500 | |
| DGR MR | 33.61% | -13.74% |
| DGR TTM | 10.93% | 6.60% |
| DGR 3 years | 9.55% | 5.24% |
| DGR 5 years | 8.43% | 5.40% |
| DGR 10 years | 9.44% | 7.07% |
| DGR 15 years | - | 6.12% |
| Time since last change announced | 1056 days |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 59.00 |
| Daily high | 60.70 |
| Daily low | 58.30 |
| Daily Volume | 9K |
| All-time high | 69.90 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | 2.88 |
| Ex-div date | 22 Dec 2022 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| EQL.ST | S&P500 | |
| Current price drop from All-time high | -15.45% | -1.10% |
| Highest price drop | -18.03% | -19.00% |
| Date of highest drop | 22 Oct 2025 | 8 Apr 2025 |
| Avg drop from high | -11.20% | -2.76% |
| Avg time to new high | 9 days | 5 days |
| Max time to new high | 26 days | 89 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
Employees
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
EQL Pharma (OM:EQL) is forecasting robust growth, with earnings expected to climb 59.6% per year and revenue set to increase 30.4% per year, both well ahead of broader Swedish market expectations. How...
November 6, 2025
Despite a challenging quarter with supply chain disruptions, EQL Pharma AB (OSTO:EQL) focuses on strategic launches and market expansions to drive future growth.
November 5, 2025